Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vasil'ev

Showing results (811-820 of 1,470) with videos related to

Pageof 147
Sort By:
Klinicheskaia Meditsina|October 3, 2003
[Spiral computed tomography with functional tests in diagnosis of chronic obstructive diseases of the lungs]A Iu Vasil'ev, N K Vit'ko, N N Trishina, et al.
Izvestiia Akademii Nauk. Seriia Biologicheskaia|October 31, 2007
[Expression and function of p63 gene in epithelial cells]E A Voroteliak, E S Chermnykh, S B Tkachenko, et al.
Genetika|November 10, 2007
[Novel BRCA1 gene mutations in breast cancer patients from St. Petersburg]O S Tikhomirova, N A Grudinina, V I Golubkov, et al.
Klinicheskaia Meditsina|March 18, 2015
[Familial hypercholesterolemia due to a new mutation in the low density lipoprotein receptor gene]V A Korneva, T Iu Bogoslovskaia, T Iu Kuznetsova, et al.
Voprosy Meditsinskoi Khimii|May 1, 1986
[Changes in protein kinase activity of the skin in cancer]I D Grozdova, A V Mikhaĭlovskiĭ, I R Eshba, et al.
Terapevticheskii Arkhiv|January 1, 1986
[Decreased effectiveness of cold-induced heparin precipitation of plasma fibronectin in infection]S A Vasil'ev, E E Efremov, G A Ermolin, et al.
Oncogene|July 16, 2002
Connexin 43, but not connexin 32, is mutated at advanced stages of human sporadic colon cancerMichael V Dubina, Nikolay A Iatckii, Dimitrii E Popov, et al.
Problemy Tuberkuleza|February 21, 2003
[Long-term results of prolonged treatment in patients with fibrosing alveolitis (prophylactic medical examination)]L V Ozerova, I P Zaĭtseva, L A Popova, et al.
Khirurgiia|November 7, 2002
[Diagnosis and treatment of syndrome of multiple endocrine neoplasia type 2]N S Kuznetsov, D G Bel'tsevich, E Iu Poliakova, et al.
Antibiotiki|June 1, 1975
[Dicloxacillin: its chemotherapeutic action and experimental kinetic characteristics]A N Lobuseva, V K Vasil'ev, E K Berezina, et al.
Pageof 147

Showing results (811-820 of 1,470) with videos related to

Sort By:
Pageof 147
Klinicheskaia Meditsina|October 3, 2003
[Spiral computed tomography with functional tests in diagnosis of chronic obstructive diseases of the lungs]A Iu Vasil'ev, N K Vit'ko, N N Trishina, et al.
Izvestiia Akademii Nauk. Seriia Biologicheskaia|October 31, 2007
[Expression and function of p63 gene in epithelial cells]E A Voroteliak, E S Chermnykh, S B Tkachenko, et al.
Genetika|November 10, 2007
[Novel BRCA1 gene mutations in breast cancer patients from St. Petersburg]O S Tikhomirova, N A Grudinina, V I Golubkov, et al.
Klinicheskaia Meditsina|March 18, 2015
[Familial hypercholesterolemia due to a new mutation in the low density lipoprotein receptor gene]V A Korneva, T Iu Bogoslovskaia, T Iu Kuznetsova, et al.
Voprosy Meditsinskoi Khimii|May 1, 1986
[Changes in protein kinase activity of the skin in cancer]I D Grozdova, A V Mikhaĭlovskiĭ, I R Eshba, et al.
Terapevticheskii Arkhiv|January 1, 1986
[Decreased effectiveness of cold-induced heparin precipitation of plasma fibronectin in infection]S A Vasil'ev, E E Efremov, G A Ermolin, et al.
Oncogene|July 16, 2002
Connexin 43, but not connexin 32, is mutated at advanced stages of human sporadic colon cancerMichael V Dubina, Nikolay A Iatckii, Dimitrii E Popov, et al.
Problemy Tuberkuleza|February 21, 2003
[Long-term results of prolonged treatment in patients with fibrosing alveolitis (prophylactic medical examination)]L V Ozerova, I P Zaĭtseva, L A Popova, et al.
Khirurgiia|November 7, 2002
[Diagnosis and treatment of syndrome of multiple endocrine neoplasia type 2]N S Kuznetsov, D G Bel'tsevich, E Iu Poliakova, et al.
Antibiotiki|June 1, 1975
[Dicloxacillin: its chemotherapeutic action and experimental kinetic characteristics]A N Lobuseva, V K Vasil'ev, E K Berezina, et al.
Pageof 147